BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 10599151)

  • 1. Changes in the volume of residual pituitary adenomas in patients with adult-onset growth hormone deficiency during replacement therapy with the recombinant human growth hormone.
    Finkenstedt G; Höfle G; Pallua A; Sailer U; Gasser RW
    Wien Klin Wochenschr; 1999 Nov; 111(21):887-90. PubMed ID: 10599151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Night sleep EEG and daytime sleep propensity in adult hypopituitary patients with growth hormone deficiency before and after six months of growth hormone replacement.
    Schneider HJ; Oertel H; Murck H; Pollmächer T; Stalla GK; Steiger A
    Psychoneuroendocrinology; 2005 Jan; 30(1):29-37. PubMed ID: 15358440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic resonance imaging after transsphenoidal surgery of clinically non-functional pituitary macroadenomas and its impact on detecting residual adenoma.
    Kremer P; Forsting M; Ranaei G; Wüster C; Hamer J; Sartor K; Kunze S
    Acta Neurochir (Wien); 2002 May; 144(5):433-43. PubMed ID: 12111499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereotactic conformal radiotherapy for pituitary adenomas: technique and preliminary experience.
    Jalali R; Brada M; Perks JR; Warrington AP; Traish D; Burchell L; McNair H; Thomas DG; Robinson S; Johnston DG
    Clin Endocrinol (Oxf); 2000 Jun; 52(6):695-702. PubMed ID: 10848873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GH replacement in patients with non-functioning pituitary adenoma (NFA) treated solely by surgery is not associated with increased risk of tumour recurrence.
    Arnold JR; Arnold DF; Marland A; Karavitaki N; Wass JA
    Clin Endocrinol (Oxf); 2009 Mar; 70(3):435-8. PubMed ID: 19236640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Natural history study of postoperative residual non-functioning pituitary adenomas].
    Wu ZB; Chen Y; Lü QP; Wang CD; Su ZP; Wu JS; Zheng WM; Zhuge QC
    Zhonghua Yi Xue Za Zhi; 2010 Mar; 90(9):597-600. PubMed ID: 20450781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fractionated stereotactic conformal radiotherapy for secreting and nonsecreting pituitary adenomas.
    Minniti G; Traish D; Ashley S; Gonsalves A; Brada M
    Clin Endocrinol (Oxf); 2006 May; 64(5):542-8. PubMed ID: 16649974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac dimension and function in patients with childhood onset growth hormone deficiency, before and after growth hormone retreatment in adult age.
    Feinberg MS; Scheinowitz M; Laron Z
    Am Heart J; 2003 Mar; 145(3):549-53. PubMed ID: 12660681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status.
    Mukherjee A; Murray RD; Teasdale GM; Shalet SM
    Clin Endocrinol (Oxf); 2004 Apr; 60(4):476-83. PubMed ID: 15049963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pituitary adenomas treated with gamma knife radiosurgery: volumetric analysis of 100 cases with minimum 3 year follow-up.
    Pamir MN; Kiliç T; Belirgen M; Abacioğlu U; Karabekiroğlu N
    Neurosurgery; 2007 Aug; 61(2):270-80; discussion 280. PubMed ID: 17762739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumour surveillance imaging in patients with extrapituitary tumours receiving growth hormone replacement.
    Chung TT; Drake WM; Evanson J; Walker D; Plowman PN; Chew SL; Grossman AB; Besser GM; Monson JP
    Clin Endocrinol (Oxf); 2005 Sep; 63(3):274-9. PubMed ID: 16117814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereotactic radiotherapy for the treatment of pituitary adenomas.
    Selch MT; Gorgulho A; Lee SP; Mattozo C; Solberg TD; Agazaryan N; Desalles AA
    Minim Invasive Neurosurg; 2006 Jun; 49(3):150-5. PubMed ID: 16921455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of growth hormone substitution on cognitive performance in adult patients with hypopituitarism.
    Oertel H; Schneider HJ; Stalla GK; Holsboer F; Zihl J
    Psychoneuroendocrinology; 2004 Aug; 29(7):839-50. PubMed ID: 15177699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Serum tumor marker levels during a 12-months growth hormone replacement therapy in patients with adult growth hormone deficiency].
    Hubina E; Kovács L; Szabolcs I; Rimanóczy E; Czirják S; Góth M
    Orv Hetil; 2002 Mar; 143(12):601-5. PubMed ID: 11963397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolated growth hormone (GH) deficiency in adult patients: baseline clinical characteristics and responses to GH replacement in comparison with hypopituitary patients. A sub-analysis of the KIMS database.
    Abs R; Mattsson AF; Bengtsson BA; Feldt-Rasmussen U; Góth MI; Koltowska-Häggström M; Monson JP; Verhelst J; Wilton P;
    Growth Horm IGF Res; 2005 Oct; 15(5):349-59. PubMed ID: 16168692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term follow-up of patients with pituitary macroadenomas after postoperative radiation therapy: analysis of tumor control and functional outcome.
    Langsenlehner T; Stiegler C; Quehenberger F; Feigl GC; Jakse G; Mokry M; Langsenlehner U; Kapp KS; Mayer R
    Strahlenther Onkol; 2007 May; 183(5):241-7. PubMed ID: 17497095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integration of surgery with fractionated stereotactic radiotherapy for treatment of nonfunctioning pituitary macroadenomas.
    Paek SH; Downes MB; Bednarz G; Keane WM; Werner-Wasik M; Curran WJ; Andrews DW
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):795-808. PubMed ID: 15708259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereotactic conformal radiotherapy in patients with growth hormone-secreting pituitary adenoma.
    Milker-Zabel S; Zabel A; Huber P; Schlegel W; Wannenmacher M; Debus J
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1088-96. PubMed ID: 15234043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endoscopic endonasal transsphenoidal surgery for pituitary tumors.
    Shen CC; Wang YC; Hua WS; Chang CS; Sun MH
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Apr; 63(4):301-10. PubMed ID: 10820909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endoscopic transsphenoidal treatment in recurrent and residual pituitary adenomas--first experience.
    Rudnik A; Zawadzki T; Gałuszka-Ignasiak B; Bazowski P; Duda I; Wojtacha M; Rudnik AI; Krawczyk I
    Minim Invasive Neurosurg; 2006 Feb; 49(1):10-4. PubMed ID: 16547875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.